Nano-X Imaging (NNOX) has released an update.
Nano-X Imaging Ltd. reported its Q1 2024 financial results, revealing a slight revenue increase to $2.6 million and a net loss of $12.2 million, which is marginally higher than the previous year. The company highlighted the acceleration of Nanox.ARC deployment in the U.S. and the securing of two commercial agreements for their Nanox.AI product suite. Despite the net loss, the company is advancing its commercial and operational performance, including a demonstration of Nanox.ARC’s clinical utility and partnerships to strengthen customer support.
For further insights into NNOX stock, check out TipRanks’ Stock Analysis page.
